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Abstract 
DAX-1 is known to play a key role in the maintenance of pluripotency in 
mouse embryonic stem cells (mESC), such that elimination of DAX-1 (through 
methods such as RNAi) leads to the differentiation of ESC (Khalfallah et al. 
2009). Earlier research by the Tzagarakis-Foster lab identified target genes of 
DAX-1 in mESC through PCR array methodology (Torres 2013). The Dickkopf 1 
gene (Dkk1) was identified as a potential target of DAX-1 by these studies and 
has since been confirmed to be a DAX-1 target in mESC. However, to date very 
little is understood of the mechanism of DAX-1 repression of Dkk1 in mESC.  In 
order to better understand the relationship between DAX-1 and Dkk1 in mESC, 
DAX-1 was knocked down via RNAi and levels of gene expression were 
measured by qPCR. We found that Dkk1 gene expression exhibited more than a 
twofold increase in mESCs that had a DAX-1 knockdown, which supports our 
hypothesis that DAX-1 acts as a negative transcriptional regulator of Dkk1.  
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Introduction 
Wnt Signaling 
The Wnt (wingless/integration1) signaling pathway is a signal 
transduction cascade that is key mediator of both embryonic 
development from Drosophila to mammals as well as certain cancers 
(Wodarz and Nusse 1998; Logan and Nusse 2004). In embryonic 
development, the Wnt pathway has many roles, including anterior-
posterior axial patterning, somitogenesis, angiogenesis, vasculogenesis, 
and limb, bone, tooth and eye formation (Logan and Nusse 2004; Katoh 
2007). Wnt signaling is activated by the release of Wnt proteins, which 
can act in either an autocrine or paracrine fashion.  
The Wnt proteins are a family of glycoproteins that are 350-400 
amino acids long and have either 23 or 24 conserved cysteine residues.  
Additionally, all Wnt proteins share a common CKCHGXSGXC motif 
(Mikels and Nusse 2006).  In mammals, 19 Wnt proteins have been 
identified. The diversity of the Wnt family of proteins is conserved across 
species from cnidarians (Hydra) to humans. However, to date they have 
not been found in prokaryotes, unicellular eukaryotes, or plants (Miller 
2001). This suggests that Wnt signaling is necessary for the 
development of most multicellular organisms (Amerongen and Nusse 
2009).  Wnt proteins are generally split into two groups. The first group 
includes the canonical Wnt ligands.  These Wnt proteins signal to 
stabilize β-catenin, which combines with the TCF/LEF (TCell 
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Factor/Lymphoid Enhancer Factor) complex to change transcription of 
target genes (Kawano and Kypta 2003).  The second group includes the 
non-canonical Wnt ligands.  Wnt proteins in this group activate other 
signaling pathways, such as the Wnt/Ca2+ or Wnt/polarity pathway 
(Miller 2001).  
The canonical Wnt signaling pathway is activated when secreted 
Wnt proteins bind to the seven transmembrane domain receptor Fz 
(Frizzled) as well as LRP 5/6 (Low-Density Lipoprotein Related Receptor 
Protein 5 or 6).  These three molecules form a complex that recruits the 
protein Dvl (Dishevelled) (MacDonald et al. 2009).  Dvl then recruits Axin, 
a scaffold protein, to the complex, binding to its PPPSPXS motifs of LRP 
5/6. Axin also recruits GSK-3β (Glycogen Synthase Kinase-3β) and CK1 
(Casein Kinase 1), which in turn phosphorylate LRP 5/6 on all five of its 
PPPSPXS motifs.  This phosphorylation is essential for signaling 
downstream in the pathway (Figure 1) (Tamai et al. 2004). Loss of Axin 
from the Axin complex leads to a failure of GSK-3β and CK1 to 
phosphorylate β-catenin and mark it for degradation.  Free β-catenin is 
then allowed to accumulate in the cytosol and eventually enter the 
nucleus, where it works with other transcription factors, such as TCF/LEF, 
to regulate the transcription of target genes (MacDonald et al. 2009).  
 
 
 
 10 
 
 
Figure 1: Fz/LRP5/6 complex stabilization. Binding of Wnt to Fz 
and LRP5/6 recruits Axin, which recruits GSK-3β and CK1. GSK-3β 
and CK1 phosphorylate all five PPPSPXS motifs on LRP5/6, which 
is essential for downstream signaling. 
 
When Wnt is not bound to Fz and LRP5/6, β-catenin is degraded 
via the Axin complex, which is composed of the proteins Axin, GSK-3β, 
APC (Adenomatous Polypsis Coli), and CK1. Axin has separate domains 
that interact with GSK-3β, CK1, and β-catenin, ultimately positioning the 
complex to be able to phosphorylate β-catenin. Once oriented correctly, 
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GSK-3β phosphorylates β-catenin on residues Thr 41, Ser 37, and Ser 
33; CK1 will then phosphorylate β-catenin on residue Ser 45. Additionally, 
GSK-3β and CK1 will phosphorylate both Axin and APC, enhancing the 
association of the complex and therefore phosphorylation of β-catenin 
(Kimelman and Xu 2006).  Phosphorylated β-catenin is then recognized 
by β-Tcrp, which ubiquitinates it, marking it for degradation by the 
proteasome (Figure 2). 
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Figure 2: Wnt Signaling. In the absence of Wnt ligands, cytosolic 
β-catenin is continuously phosphorylated within the β-catenin 
destruction complex, which consists of APC, GSK3β, CK1 and Axin. 
Phosphorylated β-catenin is targeted for ubiquitin-dependent 
proteasomal degradation in the cytosol. Upon Wnt binding to to Fz 
and LRP6, β catenin accumulates in the cytosol and translocates 
into the nucleus and interacts with TCF/LEF1 for activation of Wnt-
 13 
responsive genes (http://docs.abcam.com/pdf/stemcells/Wnt-
signaling-pathway.pdf, November 28, 2014). 
Dkk1 
The Dickkopf (Dkk) family is a group of glycoproteins that are known to 
interact with components of the Wnt pathway. The Dkks have two 
conserved cysteine rich domains, Cys-1 and 2.  Structurally, the Dkks are 
similar to proteins in the colipase family, especially in the Cys-2 domain 
(Figure 3) (Krupnik et al. 1999). The homology between the Cys-2 domains 
of the two families suggests that the two families could function in a similar 
function.  Indeed, colipases are known to interact with lipids, suggesting 
that Dkks could possibly use this lipid interaction to associate with the cell 
membrane, where Wnt proteins are known to associate. This relationship 
suggests a mechanism that facilitates Wnt protein-Dkk interaction (Aravind 
and Koonin 1998).  
The four members of the Dkk family, Dkk1, 2, 3, and 4 are fairly 
evolutionarily conserved across most organisms (including humans), with 
the exception of Caenorhabditis elegans and Drosophila melanogaster 
(Nierhs 2006). Dkk1 inhibits the Wnt pathway by binding to LRP 5/6, which 
blocks the Wnt-Fz complex from binding LRP 5/6. Additionally, Dkk1 
binding to LRP5/6 can induce endocytosis of LRP from the cell membrane 
(Cruciat and Niehrs 2013). Although disputed, there is evidence that it can 
also inhibit Wnt signaling by binding to the Kremen 1 and 2 cell surface 
receptors (Mao et al. 2002). Upon Dkk1 binding to both LRP and Kremen, 
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endocytosis of LRP from the cell membrane is induced (Kawano and Kypta 
2003).  
 
 
Figure 3: Conserved Cysteine domains in the Dkk family and their 
homology with the Colipase family. 
 
DAX-1 
DAX-1 (Dosage sensitive sex reversal, Adrenal hypoplasia congenita, 
critical region on the X chromosome, gene 1) is an orphan nuclear 
hormone receptor encoded by the gene NR0B1. The Nuclear Hormone 
Receptor (NHR) superfamily is a group of transcription factors that act to 
enter the nucleus and change target gene expression. They can act in 
different ways, but are mostly active upon ligand binding, which is usually a 
hormone (Figure 4). However, certain NHRs, such as DAX-1, do not have a 
ligand, and are identified as orphan Nuclear Hormone Receptors (Aranda 
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and Pascual 2001).  
 
 
Figure 4: Mechanisms of activation of NHRs. 1. A ligand is synthesized 
in another cell and binds to the NHR in the cytoplasm. 2. A ligand is 
synthesized within the cell and binds to the NHR in the cytoplasm. 3. A 
ligand is metabolized in the cell and the metabolite binds the NHR in the 
cytoplasm. In all three cases, ligand binding allows the NHR to translocate 
to the nucleus. Once the NHR is in the nucleus, it will generally form a 
dimer or be part of a larger protein complex in order to change transcription 
of target genes. 
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Typical NHR structure starts with the N-terminal domain, which is adjacent 
to the DNA Binding Domain (DBD). The hinge region follows, which is 
located between the DBD and Ligand Binding Domain (LBD). The C-
terminal domain is located next to the LBD and flanks the end of the protein 
(Figure 5).  
 
Figure 5: Typical NHR Structure. First, a linear depiction of NHR structure: the 
N-terminal domain (A/B), DBD (C), Hinge region (D), LBD (E), and C-terminal 
domain (F). Additionally, the three dimensional structure of an NHR’s (Estrogen 
Receptor Alpha) DBD binding DNA and LBD binding ligand. 
(http://upload.wikimedia.org/wikipedia/commons/3/3e/Nuclear_Receptor_Structur
e.png, November 24, 2014) 
 
The N-terminal domain of NHRs often contains a hypervariable AF-1 
(Autonomous transcriptional activation Function) domain that is responsible 
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for ligand independent activation of the NHR.  The AF-1 domain allows 
NHRs to be promoter or cell-specific, which contributes to the NHR’s 
specificity.  Additionally, the N-terminal domain can be modified via 
phosphorylation, thereby modifying the function of the NHR (Aranda and 
Pascual 2001). 
The DBD allows NHRs to recognize specific sequences of DNA. It has 
conserved Cys residues that form two zinc finger motifs, which allow the 
NHR to bind to the major groove of DNA. The hinge region of the NHR links 
the DBD and LBD and allows for rotation in the DBD. The hinge may 
contain nuclear localization signals, and possibly play a role in binding to 
other proteins (Aranda and Pascual 2001). Finally, the LBD is a 
multifunctional domain that is the site of ligand binding as well as mediation 
of dimerization and interaction with other proteins. It can also contain an 
AF-2 domain, which is similar to the AF-1 domain but functions in ligand-
dependent transcriptional change (Wurtz et al. 1996). 
DAX-1 is a unique NHR that has several key differences from the typical 
NHR. One difference is that DAX-1 has no known ligand, making it an 
orphan NHR. This could be due to the fact that the LBD and C-terminal 
domain are only partially conserved. Interestingly, even though it doesn’t 
have a known ligand, it does have an AF-2 domain, which is dependent on 
a ligand to cause transcriptional change. It also carries a 26 amino acid 
long insertion in the LBD that is not found in other NHRs. Because this 
insertion is conserved in both mouse and humans, it could possibly play a 
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role in DAX-1 functionality (Lalli 2014). Another difference can be found in 
the DBD. DAX-1 lacks the typical zinc finger motifs of a NHR. Rather, it has 
a novel Cys-rich domain of about 70 amino acids, containing three LXXLL 
repeats, which are thought to have some function in the ability to regulate 
transcription (Ehrlund and Treuter 2012). 
In early embryonic development, DAX-1 plays a key role in the 
development of the adrenal glands as well as gonads (Niakan and McCabe 
2005). In males, the presence of the Y chromosome leads to expression of 
SRY (Sex-determining Region Y), also known as TDF (Testes Determining 
Factor). SRY activates the expression of SOX9 (SRY-related HMG box9) 
and inhibits the expression of DAX-1, which allows for the expression of SF 
(Steroidogenic Factor 1). Together, SOX9 and SF1 will lead to the 
development of testes. In females, the absence of the Y chromosome, and 
therefore SRY, leads to the expression of DAX-1, inhibition of SOX9 and 
SF1, and the development of the ovaries (Figure 6).    
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Figure 6: Interaction between SRY and DAX-1 in males versus 
females. In males, SRY will activate inhibit the expression of SOX9, while 
inhibiting the expression of DAX-1. These inhibitions allow SF1 to be 
expressed, which allow SF1 and SOX9 to differentiate primordial germ cells 
into the Leydig (Interstitial) and Sertoli (Sustentacular) cells of the testes.  
In females, there is no SRY present, allowing DAX-1 to inhibit the 
expression of SF1, which allows primordial germ cells to differentiate (by 
default) into the follicular, theca, and granulosa cells of the ovaries. 
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Given DAX-1’s known role in the transcriptional regulation of genes in 
early embryonic development (Torres 2013), my thesis further investigates 
the transcriptional regulation of DAX-1 upon Dkk1. Specifically, I aim to 
demonstrate that DAX-1 is a negative regulator of Dkk1 during early 
embryonic development by comparing levels of gene expression between 
untreated mESC and mESC treated with siRNA to knockdown DAX-1. By 
artificially decreasing DAX expression via RNAi, I expect Dkk1 expression 
levels to increase.  
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Materials and methods 
 
Cell Culture 
mESC were cultured with a modified Dulbecco’s Modified Eagle Medium 
(DMEM) in a 75mL flask that  was pretreated with a 0.1% gelatin solution for at 
least one hour prior to passage. 15% fetal bovine serum, 1% non-essential 
amino acids, 1% penicillin/streptomycin, 50 µL leukemia inhibitory factor, 7 µL 
basal medium eagle, 12 mL L-glucose, and 10 mL sodium bicarbonate were 
added to the modified DMEM.  Briefly, cells were first washed with 6 mL of 
Phosphate Buffered Saline (PBS) and then treated with 2 mL of trypsin. After five 
minutes of incubation, a sample of suspended cells was removed and pelleted at 
1,000x g for five minutes. Cells were resuspended in 6 mL of DMEM and 
passaged in a 1:10 ratio.  
 
DAX-1 Knockdown 
DAX-1 gene expression was knocked down by RNAi as outlined by Alexandra 
Maramba (Maramba 2015).  
 
RNA Isolation 
Total RNA was collected from mESC after cell culture using the Qiagen RNA 
Easy miniprep kit. Briefly, before RNA collection, treated and untreated mESC 
were treated with trypsin and spun for five minutes at 1000x g. The centrifuged 
pellet was washed with 1X PBS and treated with 350 µL of Buffer RLT, disrupting 
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the pellet. The cells were vortexed for 10 seconds, and homogenized by passing 
cells through an 18 gauge needle attached to a syringe at least 10 times. 350 µL 
of 70% ethanol were added to the homogenized lysate and mixed by pipetting. 
700 µL of the sample were transferred to an RNeasy spin column inside a 2 mL 
collection tube. The cell lysate was centrifuged at 8,000x g for 15 seconds. 700 
µL of Buffer RW1 were added to the column after the flow-through was 
discarded. The column was again spun for 15 seconds at 8,000x g. After 
discarding the flow-through, 500 µL of Buffer RPE were added to the column and 
spun for 15 seconds at 8,000x g (for a total of two times). Finally, the column was 
placed in a new collection tube and 30 µL of water were added to the column and 
spun for one minute at 8,000x g to elute the RNA. RNA concentration was 
measured using a Nanodrop spectroscope. 
 
cDNA Synthesis 
cDNA was synthesized via the New England Biolabs First Strand cDNA 
Synthesis kit.  First, 500 ng of RNA and two µL of random primer mix were added 
in an RNase free microfuge tube and heated to 70°C for five minutes in order to 
denature the RNA. Then, 10 µL of M-MuLV Reaction Mix and two µL of M-MuLV 
Enzyme mix were added to the tube. The tube was heated to 25°C for five 
minutes, followed by 42°C for one hour, ending with 80°C for five minutes. The 
cDNA was then diluted to 50 µL by adding 30 µL of PCR grade water. 
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Polymerase Chain Reaction and Gel Electrophoresis 
Polymerase Chain Reaction (PCR) was performed in 20 µL reactions with 10 µL 
of Go Green Master Mix, 0.125 µL forward primer, 0.125 µL reverse primer, 7.75 
µL PCR grade water, and two µL cDNA. All PCR reactions were performed as 
follows:  
1. 95° five minutes 
2. 95° 30 seconds 
3. 58° 30 seconds 
4. 72° 45 seconds 
5. Repeat steps 2 through 4 30 times 
6. 72° five minutes 
After the PCR reaction was completed, the samples were electrophoresed at 110 
Volts through a 2% agarose gel (in 1XTAE) containing ethidium bromide for 30 
minutes and then visualized.  
Table 1: Primers and Melting Temperatures used for PCR and qPCR of 
mESC cDNA. 
 
Gene Name Forward Primer 
(5’3’) 
Reverse Primer 
(5’3’) 
PCR Annealing 
Temp (°C) 
DAX-1 TCC TGT ACC GCA 
GCT ATG TG 
TCG AAG TGC 
AGG TGA TCT TG 
 
57°C 
Dkk1 GAG GGG AAA TTG 
AGG AAA GC 
AGC CTT CTT GTC 
CTT TGG TG 
57°C 
GAPDH ACA GCC GCA TCT 
TCT TGT GCA 
GGG CTT GAC 
TGT GCC GTT GAA 
 
57°C 
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Quantitative Polymerase Chain Reaction (qPCR) 
qPCR was performed in 20µL reactions with 10 µL of iQ qPCR Master Mix (Bio-
Rad), 0.2µL CXR reference dye, 0.250 µL forward primer, 0.250 µL reverse 
primer, 8.3 µL PCR grade water, and 1 µL cDNA. All qPCR reactions were 
performed as follows:  
1. 95° five minutes 
2. 95° 30 seconds 
3. 58° 30 seconds 
4. 72° 45 seconds 
5. Repeat 2-4 30 times 
6. 72° five minutes 
Quantitative PCR was used to compare the gene expression of both Dkk1 and 
DAX-1 in untreated and RNAi DAX-1 knockdown mESC samples. GAPDH was 
used as a control.  Each qPCR reaction was run in triplicate. Gene expression 
was measured via change in Cycle Threshold values (ΔΔCt). Ct values are 
measured by the amount of cycles in a qPCR reaction are necessary to reach a 
threshold value of fluorescence, which correlates to the amount of gene product 
existing in the reaction. ΔCt values are then calculated by subtracting the Ct 
values of the control (GAPDH) from target genes (Dkk1, DAX-1). ΔΔCt values 
are then calculated from this (2^-ΔCt). 
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Results 
DAX-1 is known to play a role in maintaining the pluripotent state of 
mESC. However, a thorough examination of essential genes regulated by Dax-1 
expression has not been elucidated.  As part of her thesis research in the 
Tzagarakis-Foster lab, Alexandra Maramba utilized an siRNA mediated gene 
knockdown method to significantly reduce the amount of DAX-1 expression in 
mESC. I confirmed DAX-1 knockdown via Western Blot (Figure 7) and then used 
this method to measure the levels of gene expression of Dkk1, and how levels 
changed with and without the presence of DAX-1 in mESC. To compare levels of 
gene expression, I calculated ΔΔCt values from qPCR data.  
                           
Figure 7: Confirmation of DAX-1 knockdown via Western Blot. 
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Figure 8: PCR Optimization of Melting Temperatures. Results of PCR 
amplification of Dkk1, DAX-1, and GAPDH at 57°C visualized on 1.5% agarose 
gel. 
First, qPCR conditions were optimized via PCR. Melting temperatures for 
DAX-1 and Dkk1 as well as the control (GAPDH) were determined to be 57°C 
(Figure 8). After optimization, qPCR was performed. As seen in figure 9, ΔΔCt 
values for DAX-1 exhibit more than a twofold decrease from untreated cells to 
the mESC treated with 80pM DAX-1 siRNA. These values range from a ΔΔCt 
value of 10.03 in the untreated cells, to 4.33 for the 20pM DAX-1 knockdown, to 
3.76 for the 80pM knockdown. Dkk1 ΔΔCt values exhibited more than a twofold 
increase when comparing untreated cells to the cells that had a DAX-1 
PCR	Op miza on,	UT	mESC,	57°	C		
Dkk1,	125	bp	
DAX-1,	336	bp	
GAPDH,	219	bp	
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knockdown. These values ranged from 0.41 in the untreated cells, to 0.85 in 20 
pM knockdown cells, to .099 in the 80 pM knockdown cells (Figure 10).   
 
 
Figure 9: Comparison of ΔΔCt Values of DAX-1 and Dkk1. A graphical 
comparison of ΔΔCt values of DAX-1 and Dkk1 in untreated (NC) and DAX-1 
knockdown mESC. 
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Figure 10: ΔΔCt Values of Dkk1. A graphical representation showing the 
increase in ΔΔCt values of Dkk1 from untreated mESC to DAX-1 knockdown 
mESC. 
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Discussion 
Although Wnt signaling is one of the major signaling pathways in areas of 
biology such as development and cancer biology, little is known about one of its 
inhibitors, Dkk1.  In this Honors Thesis Research Project, I investigated the 
relationship between Dkk1 and DAX-1. The results of the qPCR data agree with 
my hypothesis that DAX-1 is a negative regulator of Dkk1 gene expression. This 
agreement is supported by the over twofold increase in gene expression of Dkk1 
when DAX-1 is knocked down. Additionally, another interesting fact revealed by 
the qPCR data is that the overall expression level of Dkk1 is very low in mESC 
whether or not DAX-1 is expressed in the cell. Since DAX-1 is an important 
player in maintaining pluripotency, it is expected that the level of DAX-1 
expression should be relatively high. However, in untreated cells, the gene 
expression levels of DAX-1 are 50 times that of Dkk1. Although further research 
is necessary, these data suggest that Dkk1 could be a player in the loss of 
pluripotency. In fact, part of DAX-1’s major role in pluripotency could be to make 
sure Dkk1 expression is kept low.  
 There are a few possible extensions of this research project. First, one 
could quantify the protein expression of both DAX-1 and Dkk1 via western blot to 
compare with the results of the qPCR. I would expect these levels of expression 
to agree with one another, and find that in untreated cells, there is a large 
amount of DAX-1 and little or no Dkk1. In cells with DAX-1 knocked down, I 
would expect to find little or no DAX-1 protein product while having a slight 
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increase in the amount of Dkk1. Most likely, one would have to perform an 
immunoprecipitation in order to achieve significant protein data.  
Another extension of this project is to perform a CHIP (Chromatin 
Immunoprecipitation) Assay in order to discover what proteins, along with DAX-1, 
are binding to the promoter of Dkk1 to decrease its gene expression. It is highly 
unlikely that DAX-1 binds by itself to the promoter since it usually acts as part of 
a greater protein complex. Several proteins significant in the maintenance of 
pluripotency have already been shown to bind either to the Dkk1 promoter in 
primary literature such as β-catenin, TCF, Nanog, Oct4, Pou5f1, Otx2, and 
MesP. The CHIP assay would be used to investigate whether or not these 
proteins do bind with DAX-1 to the Dkk1 promoter.  
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